345
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Systematic exploration of network pharmacology, in silico modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome

ORCID Icon & ORCID Icon
Article: FSO952 | Received 18 Oct 2023, Accepted 07 Dec 2023, Published online: 17 Apr 2024

References

  • Azziz R. Introduction. Fertil. Steril. 106(1), 4–5 (2016).
  • Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106(1), 6–15 (2016).
  • Dokras A, Sarwer DB, Allison KC et al. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J. Clin. Endocrinol. Metab. 101(8), 2966–2974 (2016).
  • Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol. Metab. 36(2), 296–311 (2021).
  • Tanbo T, Mellembakken J, Bjercke S, Ring E, Åbyholm T, Fedorcsak P. Ovulation induction in polycystic ovary syndrome. Acta Obstet. Gynecol. Scand. 97(10), 1162–1167 (2018).
  • Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98(4), 2133–2223 (2018).
  • Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics and immunology of polycystic ovarian syndrome (PCOS). J. Assist. Reprod. Genet. 39(11), 2439–2473 (2022).
  • Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation and hyperandrogenism. Int. J. Mol. Sci. 23(8), 4110 (2022).
  • Teede HJ, Misso ML, Costello MF et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 110(3), 364–379 (2018).
  • Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics 137(5), (2016).
  • Legro RS, Arslanian SA, Ehrmann DA et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 98(12), 4565–4592 (2013).
  • Calcaterra V, Verduci E, Cena H et al. Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients 13(6), 1848 (2021).
  • Khan L. Polycystic ovarian syndrome in adolescents: keys to diagnosis and management. Pediatr. Ann. 50(7), (2021).
  • de Oliveira AM, Rondó PHC, Luzia LA, D'Abronzo FH, Illison VK. The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res. Clin. Pract. 92(2), 253–260 (2011).
  • Asbaghi O, Nazarian B, Yousefi M, Anjom-Shoae J, Rasekhi H, Sadeghi O. Effect of vitamin E intake on glycemic control and insulin resistance in diabetic patients: an updated systematic review and meta-analysis of randomized controlled trials. Nutr. J. 22(1), 10 (2023).
  • Begum RF, Mohan S. Insights into vitamin e with combined oral contraceptive on INSR gene in PCOS by integrating in silico and in vivo approaches. Appl. Biochem. Biotechnol. (2023). Available from: https://link.springer.com/ doi: 10.1007/s12010-023-04710-8
  • Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J. Cell. Physiol. 234(6), 8152–8161 (2019).
  • Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum. Reprod. Update 14(4), 345–357 (2008).
  • Begum RF, Suresh S, Devi VS, Moka MK, M S. Does vitamin E supplementation alter hormonal levels in polycystic ovary syndrome: a systematic review of randomized controlled trials. Curr. Tradit. Med. 10 (2023). Available from: https://www.eurekaselect.com/220435/article
  • Wang S, Gao H, Wang X et al. Network pharmacology and bioinformatics analyses identify intersection genes of vitamin D3 and COVID-19 as potential therapeutic targets. Front. Pharmacol. 13 (2022). Available from: https://www.frontiersin.org/articles/10.3389/fphar.2022.874637/full
  • Bhardwaj VK, Purohit R. A new insight into protein-protein interactions and the effect of conformational alterations in PCNA. Int. J. Biol. Macromol. 148, 999–1009 (2020).
  • Singh R, Bhardwaj V, Purohit R. Identification of a novel binding mechanism of Quinoline based molecules with lactate dehydrogenase of Plasmodium falciparum. J. Biomol. Struct. Dyn. 39(1), 348–356 (2021).
  • Kamaraj B, Purohit R. Mutational Analysis on Membrane Associated Transporter Protein (MATP) and Their Structural Consequences in Oculocutaeous Albinism Type 4 (OCA4)-A Molecular Dynamics Approach. J. Cell. Biochem. 117(11), 2608–2619 (2016).
  • Rajasekaran R, George Priya Doss C, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R. Effect of deleterious nsSNP on the HER2 receptor based on stability and binding affinity with herceptin: a computational approach. C. R. Biol. 331(6), 409–417 (2008).
  • Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field and Python Bindings. J. Chem. Inf. Model. 61(8), 3891–3898 (2021).
  • Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. NA-NA (2009). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jcc.21334
  • Pires DE V, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58(9), 4066–4072 (2015).
  • Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).
  • Parekh N, Lakhani S, Patel A et al. Discovery of novel CaMK-II inhibitor for the possible mitigation of arrhythmia through pharmacophore modelling, virtual screening, molecular docking and toxicity prediction. Artif. Intell. Chem. 1(2), 100009 (2023).
  • Jilani MR, Packirisamy ASB. Terpenoids and fatty acid esters from underutilized tiliaceae shrub exhibit in silico bioactivity and protein targets. Top. Catal. (2023). Available from: https://link.springer.com/ doi: 10.1007/s11244-023-01862-z
  • Kawsar SMA, Kumer A, Munia NS, Hosen MA, Chakma U, Akash S. Chemical descriptors, PASS, molecular docking, molecular dynamics and ADMET predictions of glucopyranoside derivatives as inhibitors to bacteria and fungi growth. Org. Commun. 15(2), 184–203 (2022).
  • Islam S, Hosen MA, Ahmad S et al. Synthesis, antimicrobial, anticancer activities, PASS prediction, molecular docking, molecular dynamics and pharmacokinetic studies of designed methyl α-D-glucopyranoside esters. J. Mol. Struct. 1260, 132761 (2022).
  • Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42(Web Server issue), W32–38 (2014).
  • Mandal S, Tarai SK, Patra P et al. Brief Research on the Biophysical Study and Anticancer Behavior of Pt(II) Complexes: Their DNA/BSA Binding, Molecular Docking and Cytotoxic Property. Langmuir 38(44), 13613–13625 (2022).
  • Ajala A, Uzairu A, Shallangwa GA, Abechi SE. QSAR, simulation techniques and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent. Futur. J. Pharm. Sci. 9(1), 4 (2023).
  • Kumar S, Sinha K, Sharma R, Purohit R, Padwad Y. Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPARγ/Cdk5 interaction in differentiated adipocytes. Exp. Cell Res. 383(1), 111480 (2019).
  • Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43(20), 3714–3717 (2000).
  • Amin ML. P-glycoprotein Inhibition for optimal drug delivery. Drug Target Insights 7, DTI.S12519 (2013).
  • Abdul-Hammed M, Adedotun IO, Olajide M et al. Virtual screening, ADMET profiling, PASS prediction and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols and flavonoids against COVID-19 main protease (M pro). Nat. Prod. Res. 36(12), 3110–3116 (2022).
  • AS S, Vellapandian C. In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology. Futur. Sci. OA (2023). Available from: https://www.future-science.com/ doi: 10.2144/fsoa-2023-0150
  • Adone A, Fulmali DG. Polycystic ovarian syndrome in adolescents. Cureus (2023). Available from: https://www.cureus.com/articles/114206-polycystic-ovarian-syndrome-in-adolescents
  • Tefagh G, Payab M, Qorbani M et al. Effect of vitamin E supplementation on cardiometabolic risk factors, inflammatory and oxidative markers and hormonal functions in PCOS (polycystic ovary syndrome): a systematic review and meta-analysis. Sci. Rep. 12(1), 5770 (2022).
  • Heidari H, Hajhashemy Z, Saneei P. A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome. Sci. Rep. 12(1), 19927 (2022).
  • Morsy AA, Sabri NA, Mourad AM, Mojahed EM, Shawki MA. Randomized controlled open-label study of the effect of vitamin E supplementation on fertility in clomiphene citrate-resistant polycystic ovary syndrome. J. Obstet. Gynaecol. Res. 46(11), 2375–2382 (2020).
  • Chen J, Guo Q, Pei Y et al. Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study. BMC Womens. Health 20(1), 69 (2020).
  • Galli F, Azzi A, Birringer M et al. Vitamin E: emerging aspects and new directions. Free Radic. Biol. Med. 102, 16–36 (2017).
  • Przybycień P, Gąsior-Perczak D, Placha W. Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility. Cells 11(16), 2569 (2022).
  • San-Millán JL, Escobar-Morreale HF. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin. Endocrinol. (Oxf). 72(3), 383–392 (2010).
  • Douma Z, Dallel M, Bahia W et al. Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia. Gene 741, 144560 (2020).
  • Ramos Cirilo PD, Rosa FE, Moreira Ferraz MF, Rainho CA, Pontes A, Rogatto SR. Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome. Gynecol. Endocrinol. 28(3), 190–194 (2012).
  • Kodiha M, Azad N, Chu S, Crampton N, Stochaj U. Oxidative stress and signaling through EGFR and PKA pathways converge on the nuclear transport factor RanBP1. Eur. J. Cell Biol. 103(1), 151376 (2024).
  • Lazo-de-la-Vega-Monroy M-L, Fernndez-Mej C. Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant actions. In: Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants. InTech (2013). Available from: http://www.intechopen.com/books/oxidative-stress-and-chronic-degenerative-diseases-a-role-for-antioxidants/oxidative-stress-in-diabetes-mellitus-and-the-role-of-vitamins-with-antioxidant-actions
  • Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life 71(4), 487–494 (2019).
  • Madden JC, Enoch SJ, Paini A, Cronin MTD. A review of in silico tools as alternatives to animal testing: principles, resources and applications. Altern. to Lab. Anim. 48(4), 146–172 (2020).